title: Stem cells: REGENT trial-the end of cell therapy for MI?
authors.forename: Rasmus S
authors.initials: RS
authors.lastname: Ripa
authors.forename: Jens
authors.initials: J
authors.lastname: Kastrup
mesh_terms: D019317:Evidence-Based Medicine; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic; D020127:Recovery of Function; D013318:Stroke Volume; D013997:Time Factors; D016896:Treatment Outcome; D016277:Ventricular Function, Left
references.citation: Circulation. 2006 Mar 14;113(10):1287-94
references.pmid: 16520413
references.citation: Eur Heart J. 2009 Jun;30(11):1313-21
references.pmid: 19208649
references.citation: J Am Coll Cardiol. 2008 Apr 15;51(15):1429-37
references.pmid: 18402895
references.citation: Eur Heart J. 2008 Aug;29(15):1807-18
references.pmid: 18523058
references.citation: Circ Res. 1999 Aug 6;85(3):221-8
references.pmid: 10436164
references.citation: N Engl J Med. 2006 Sep 21;355(12):1210-21
references.pmid: 16990384
references.citation: Am Heart J. 2007 Nov;154(5):929-36
references.pmid: 17967600
references.citation: Eur Heart J. 2006 Dec;27(23):2775-83
references.pmid: 17098754
references.citation: N Engl J Med. 2006 Sep 21;355(12):1199-209
references.pmid: 16990383
references.citation: Circulation. 2004 Nov 16;110(20):3213-20
references.pmid: 15533859